Of all the things Aurora Cannabis (ACB.T) does, sells, has bought, has planned, one stands out above all others as being their single most profitable business yet: Their investment in Green Organic Dutchman (TGOD.T).
A quarter billion in profit so far, that piece of good business far outweighs the returns on growing, processing, and selling medical cannabis.
In today’s Equity.Guru livestream interview on Twitch, we talk to ACB’s CCO, Cam Battley, who also sits on TGOD’s board, about how those companies found each other, what went down when ACB realized Organigram (OGI.V) had sold them tainted weed, the justification for buying Cannimed (CMED.T) at January prices in April, and much much more.
I haven’t always been too easy on Aurora, so I had a few prickly questions loaded up, and left feeling like most of them had been well answered.
Battley told us he had half an hour to chat. We kept him for nearly twice that, and could have gone another hour beyond.
— Chris Parry
FULL DISCLOSURE: TGOD is an Equity.Guru marketing client and the author owns stock and warrants in the company.